Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma
Introduction
Nodal involvement impairs survival after pancreatic resection for pancreatic adenocarcinoma (PA).1, 2, 3 The Minimal Number of Examined Lymph Nodes (MNELN) able to insure the accuracy of the nodal status assessment has been established in colorectal4 and gastric cancers5 and integrates clinical practice. As an example, adjuvant treatment after surgical resection of colorectal cancer is usually indicated for pN0 tumours if the MNELN is not reached. On the opposite, for resected PA, consensual indications of adjuvant therapies are presently independent of the nodal status.6 Adjuvant gemcitabine6 or radio-chemotherapy7, 8 are therefore proposed by most centres for N0 and N+ patients which have contributed to the scarcity of available studies on the MNELN in PA.9 Nevertheless, there are strong arguments to define the MNELN in PA. First, it would help to standardize the prognostic implications of nodal involvement in PA and the known influence of the underestimation of nodal involvement on survival curves of N0 and N+ patients by stage migration.4 Second, the refinement of the indications for adjuvant therapy that is likely to occur in the near future, and finally, the need for standardization of both surgical resections and pathological examinations in future trials of therapeutic strategies in PA. This study aims therefore to determine the MNELN ensuring reliable detection of nodal involvement in resected cephalic PA.
Section snippets
Patients
All patients who underwent pancreatoduodenectomy (PD) for cephalic PA in two universitary French centers from 1996 to 2009 were prospectively included in a computerized database and retrospectively analysed. The diagnosis of PA was confirmed by a specialized gastro-intestinal pathologist from each centre.
In both centers, liver and peritoneal metastases contraindicated PD leading to endoscopic palliatives procedures, or surgical biliary and gastric bypasses if discovered at laparotomy. Patients
Results
After application of the exclusion criteria, 188 patients were included in this study, with 122 patients from one centre (HSA) and 66 from the other one (HAP). Median age was 64 years and 117 patients (62%) were men. Eighty percent of patients had jaundice (Total bilirubin > 30 μmol/l) and 15% had a preoperative weight loss > 5%.
In 39 patients (21%), a mesentericoportal venous resection was performed. Postoperative mortality rate at 90 days was 1%. Morbidity rate was 40.2% (76 patients), with
Discussion
The prognostic value of the nodal status13, 14 described by the TNM classification and the Lymph Node Ratio1, 15, 16, 17 in cephalic PA treated by PD is confirmed here by the influence of both pN1 status and the Lymph Node Ratio > 0.2 on overall and disease free survivals. The three methods used to assess the MNELN able to ensure reliable detection of pN1 status were concordant. First, the influence of the NELN on the survival of the pN0 group of patients was almost significant despite its
Conflict of interest statement
Authors don't have any financial or personal relationships with other people or organisations that could inappropriately influence (bias) their work.
References (40)
- et al.
Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer
Surgery
(2007) - et al.
Borderline resectable pancreatic cancer: the importance of this emerging stage of disease
J Am Coll Surg
(2008) - et al.
Postoperative pancreatic fistula: an international study group (ISGPF) definition
Surgery
(2005) - et al.
Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators
J Gastrointest Surg
(2000) - et al.
Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer
J Gastrointest Surg
(2007) - et al.
The survival of stage III gastric cancer patients is affected by the number of lymph nodes removed
Surgery
(2003) - et al.
Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer
Chest
(2005) - et al.
Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma
J Gastrointest Surg
(2012) - et al.
How many lymph nodes properly stage a periampullary malignancy?
J Gastrointest Surg
(2008) - et al.
Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?
J Gastrointest Surg
(2010)
Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma
J Am Coll Surg
Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas
J Gastrointest Surg
The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer
J Gastrointest Surg
Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
Ann Surg
Pancreatic cancer surgery in the new millennium: better prediction of outcome
Ann Surg
The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined
Ann Surg Oncol
Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database
J Clin Oncol
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial
JAMA
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
N Engl J Med
Radiation therapy combined with adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Gastrointestinal Tumor Study Group
Cancer
Cited by (41)
Lymph node yield as a measure of pancreatic cancer surgery quality
2022, Surgery in Practice and ScienceDetermining the optimal number of examined lymph nodes for accurate staging of pancreatic cancer: An analysis using the nodal staging score model
2019, European Journal of Surgical OncologyCitation Excerpt :There remains a dispute regarding the optimal number of examined LNs after pancreatic surgery. Previous studies using single-institution or multicenter databases showed a wide range of cut-off values [6,11–15,33]. The drawbacks of these studies were the manual division of the examined LNs into groups and the search for a threshold that maximizes the survival differences among the groups.
Effect of adjuvant chemotherapy after pancreatectomy in patients with node-negative pancreatic cancer: target trial emulation
2024, British Journal of Surgery